Kazuhiko Ochiai
10PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 26, 2025
Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma.Tomokazu Nagashima, Kazuhiko Ochiai, Yuka Takizawa
|Apr 13, 2025
Knockdown of Methylenetetrahydrofolate Dehydrogenase/Cyclohydrolase 2 Promotes an Epithelial-Like Phenotype in Canine Mammary Carcinoma Cells.Yukino Machida, Remika Onagi, Kazuhiko Ochiai
|Feb 28, 2023
A Highly Conserved Region in BRCA2 Suppresses the RAD51-Interaction Activity of BRC Repeats.Zida Zhu, Taisuke Kitano, Masami Morimatsu
|Feb 06, 2023
Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer.Masanori Kobayashi, Moe Onozawa, Shiho Watanabe
|Dec 22, 2022
Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition.Kei Shimakawa, Kazuhiko Ochiai, Sachi Hirose
Pageof 2